Mancini Anthony, Chief Global Commercialization Officer exercised 37,450 shares of Revolution Medicines, Inc. ($RVMD) @ $33.62 ($1,259,069.00 total) on Mar 25, 2026

Mancini Anthony – Chief Global Commercialization Officer

Mar 25, 2026

52W Low$34.00

Current$140.5587.6% above low, 12.4% below high

Purchase$33.62-0.3% above low, 100.3% below high

52W High$155.70

37,450

Price

$33.62

Total Value

$1,259,069.00

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Mancini Anthony
Title	Chief Global Commercialization Officer
Transaction Date	Mar 25, 2026
Transaction Code	M Exercise/Conversion
Acquired/Disposed	Acquired
Security	Common Stock
Direct/Indirect	Direct
Filing Date	Mar 27, 2026
Shares Purchased	37,450
Price per Share	$33.62
Total Value	$1,259,069.00
Shares Owned After	91,850
Derivative	No
Accession Number	0001610717-26-000137
Document	View SEC Filing